Maplight

THERAPEUTIC AREA


Schizophrenia, Alzheimer's disease psychosis, Parkinson's disease, autism

 

 

YEAR INVESTED


2019

 

 

STAGE


Private

 

 

WEBSITE


maplightrx.com  

 

 

 

MapLight Therapeutics is a clinical stage firm developing novel therapies for CNS disorders. It aims to address unmet needs by developing innovative, targeted treatments. The company uses a circuit-based approach and proprietary platform to develop safer and more effective treatments. Its platform includes STARmap and optogenetics to identify circuit-specific targets and validate their efficacy.

hezuo-10